Alıravcı, I.D.; Mutlu, P.; Oymak, S.; Guney, U.I.; Keskin, O.
Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study. Trop. Med. Infect. Dis. 2025, 10, 190.
https://doi.org/10.3390/tropicalmed10070190
AMA Style
Alıravcı ID, Mutlu P, Oymak S, Guney UI, Keskin O.
Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study. Tropical Medicine and Infectious Disease. 2025; 10(7):190.
https://doi.org/10.3390/tropicalmed10070190
Chicago/Turabian Style
Alıravcı, Işıl Deniz, Pınar Mutlu, Sibel Oymak, Ufuk Ilter Guney, and Oguzhan Keskin.
2025. "Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study" Tropical Medicine and Infectious Disease 10, no. 7: 190.
https://doi.org/10.3390/tropicalmed10070190
APA Style
Alıravcı, I. D., Mutlu, P., Oymak, S., Guney, U. I., & Keskin, O.
(2025). Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study. Tropical Medicine and Infectious Disease, 10(7), 190.
https://doi.org/10.3390/tropicalmed10070190
